ID   DM443
AC   CVCL_F889
SY   Duke Melanoma 443
DR   Cosmic; 1477317
DR   GEO; GSM276742
DR   Wikidata; Q54831230
RX   PubMed=11520076;
RX   PubMed=19147755;
CC   From: Duke University Medical Center; Durham; USA.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
RX   PubMed=11520076; DOI=10.1006/cimm.2001.1809;
RA   Zennadi R., Abdel-Wahab Z., Seigler H.F., Darrow T.L.;
RT   "Generation of melanoma-specific, cytotoxic CD4(+) T helper 2 cells:
RT   requirement of both HLA-DR15 and Fas antigens on melanomas for their
RT   lysis by Th2 cells.";
RL   Cell. Immunol. 210:96-105(2001).
//
RX   PubMed=19147755; DOI=10.1158/1078-0432.CCR-08-1916;
RA   Augustine C.K., Yoo J.S., Potti A., Yoshimoto Y., Zipfel P.A.,
RA   Friedman H.S., Nevins J.R., Ali-Osman F., Tyler D.S.;
RT   "Genomic and molecular profiling predicts response to temozolomide in
RT   melanoma.";
RL   Clin. Cancer Res. 15:502-510(2009).
//